ICOS and neoplasm: In this regard, it has recently been shown that 4-1BB-ICOS-ζ-CAR T cells displayed tonic signaling and diminished anti-tumor efficacy in vivo compared to ICOS-4-1BB-ζ-CAR T cells [35].